Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.47 |
| ▸ | IAPP | P10997 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6139811 | 0.87 | LCK (0.67) | LCKAPPIAPPALDH1A1GAA | |
| SCHEMBL5378089 | 0.87 | LCK (0.53) | LCKAPPIAPPALDH1A1GAA | |
| SCHEMBL5370762 | 0.87 | FOLH1 (0.54) | FOLH1IAPPALDH1A1GAA | |
| SCHEMBL5371494 | 0.82 | LCK (0.58) | LCKAPPALDH1A1 | |
| SCHEMBL28349735 | 0.80 | GAA (0.60) | LCKAPPGAAPKM | |
| SCHEMBL28349736 | 0.80 | GAA (0.60) | LCKAPPGAAPKM | |
| SCHEMBL11857999 | 0.79 | LCK (0.54) | TAS1R3TAS1R1LCKFOLH1 | |
| SCHEMBL5370866 | 0.77 | ALDH1A1 (0.49) | TAS1R3TAS1R1ALDH1A1 | |
| SCHEMBL5370177 | 0.77 | IAPP (0.53) | LCKAPPIAPPALDH1A1GAA | |
| SCHEMBL18273972 | 0.76 | IAPP (0.51) | LCKAPPIAPPALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223793-B2 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2007-05-29 | — | — | US | disclosed |
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | NCEH1, HMGCR, DBH | TAS1R3 1647/4885TAS1R1 1429/4885LCK 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.